295
Malignant myoepithelioma arising in the soft palate – report
of a case
S. Suzuki
∗
, T. Sano, T. Kijima, T. Akimoto, S. Kubodera,
H. Ubukata, T. Hagino, K. Sudo, Y. Sato, S. Takaku
Department of Oral and Maxillofacial Surgery, Tokyo Nishi
Tokushukai Hospital, Japan
Background:
Malignant myoepithelioma (MM) is a rare salivary
gland neoplasm. It was first treated as an independent disease
entity in theWHO classification of salivary gland tumours in 1991.
It is a rare tumour accounting for less than 1% of salivary gland
neoplasm.
Objectives:
We present a case of MM in the soft palate and discuss
its therapeutic aspect.
Case Report:
A 76-year-old man was referred to our hospital for
evaluation of a swelling in the left soft palate, which he had been
aware of for 15 years. Recently he complained of disturbance
of swallowing. Computed tomography and magnetic resonance
imaging showed a 40 mm-in-diameter, mixed density mass in the
left palate with no obvious lymph node enlargement. Surgical
resection of the tumour was performed. Since it was diagnosed
as MM, he underwent postoperative chemoradiation. The patient
has done well with no sign of recurrence for four years.
Findings and Conclusion:
Microscopically, increase of spindle-
shaped cells and the plasmacytoid-cells were recognised in the
mucinous stroma in haematoxylin and eosin staining. In immuno-
histochemical staining, keratin 15 was positive in neoplastic cells.
In addition, the positive rate of Ki 67 was around 5%. Also, inva-
sion to capsule was observed. So it was diagnosed as MM. As
for treatment of MM, there have been a few reports and surgical
resection is the mainstay of therapy. Postoperative chemoradia-
tion is highly recommended in the case like ours, where the tumour
could not be resectedwith enough surgical margin not for technical
but for anatomical reason.
http://dx.doi.org/10.1016/j.ijom.2017.02.992Minimising postoperative pain after head and neck surgery –
the use of ultrasound guided superficial cervical plexus nerve
block immediately prior to surgery
A. Tahim
∗
, L. Cheng, A. Jones, C. Grant, S. Ali, J. Blanchard,
L. Johnston, C. Schwiebert
St Bartholomew’s, The Royal London and Homerton University
Hospitals, United Kingdom
Background:
Controlling operative pain is vital in ensuring a
comfortable and successful recovery after head and neck surgery.
The superficial cervical plexus block has been used in vascular
and thyroid surgery to reduce postoperative pain and minimise
analgesic requirement. We present our series of head and neck
patients who received this nerve block, and its effect on pain and
analgesic needs.
Methods:
A retrospective case note review was carried out for all
patients who received ultrasound guided cervical plexus blocks
prior to their procedure. Basic demographic data, nature of surgery
and intraoperative analgesia were recorded. Postoperative visual
analogue scores were noted, as was analgesia requirements and
complications.
Results:
54 patients received blocks under ultrasound guidance of
typically 10 mL of 0.5% levobupivicaine for a range of procedures
including thyroid and parathyroid surgery, neck dissections and
branchial cyst, lymph nodes and submandibular gland excision.
Intraoperative analgesia involved paracetamol, non-steroidal anti-
inflammatory drugs (NSAIDS) and stronger opioids in most cases.
96.2% and 72.2% patients used regular paracetamol and NSAIDS
postoperatively with 40.7% making use of opioid analgesia as
required. The majority of patients report pain scores between 1
and 3 postoperatively although 7.4% reported significant pain.
1.9% suffered a transient inadvertent brachial plexus block, which
resolved during the follow-up period.
Conclusion:
The ultrasound guided superficial cervical plexus
block is a useful tool in a surgeon’s armamentarium prior to head
and neck surgery. Our series demonstrates that it is well tolerated
and can be used effectively in a range of oral, maxillofacial, head
and neck surgical procedures.
http://dx.doi.org/10.1016/j.ijom.2017.02.993Neutron radiation efficacy when treating salivary gland
malignancies
M. Timoshchuk
∗
, P. Dekker, C. Davis, G. Laramore, J. Dillon
University of Washington School of Dentistry, United States
Background:
There is limited literature regarding oral complica-
tions following neutron radiotherapy (NRT)
. 1Objectives:
The aimof this followup studywas to estimate: (1) the
rates of locoregional control and (2) the frequency of oral compli-
cations in subjects with head and neck salivary gland malignancies
treated with NRT.
Methods:
This is a retrospective case series of patients with
salivary gland malignancies treated with NRT by the Radiation
Oncology Department at the UW from 1997 to 2010. Study vari-
ables were demographic, surgical, pathological, radiologic, etc.
Univariate statistics were computed for each study variable and
Kaplan–Meier methods were used to estimate locoregional recur-
rence.
Findings:
The sample was composed of 562 patients with a mean
age of 54.1 years (standard deviation, 15.9 years). 48% were
male. Adenoid cystic carcinoma (47.1%) and parotid location
(55.8%) predominated. Perineural and lymphatic invasion was
present in 49% and 26% of subjects, respectively. The six-year
locoregional control rate was 70%. Mucositis, xerostomia, and
osteoradionecrosis occurred in 81, 83, and 5.1% of subjects.
Conclusion:
The locoregional control rate of 70% compares
favourably to the rate reported in the literature for photon radiation
treatment of the same areas. The frequency of ORN was compa-
rable to photon radiation treatment of the same areas (4–7%).
Given the potential benefits of NRT, dental professionals should
be educated regarding its indications and oral complications.
Reference
1. Davis, C., Sikes, J., Namaranian, P., Laramore, G., & Dillon, J. K. (2016).
Neutron beam radiation therapy: an overview of treatment and oral com-
plications when treating salivary gland malignancies.
J Oral Maxillofac
Surg
,
74
, 830–835.
http://dx.doi.org/10.1016/j.ijom.2017.02.994




